David P Wilson
Overview
Explore the profile of David P Wilson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
237
Citations
3873
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cutts J, Quinn B, Seed C, Kotsiou G, Pearson R, Scott N, et al.
Transfus Med Hemother
. 2021 May;
48(2):118-129.
PMID: 33976612
Background And Objectives: Pre-donation screening of potential blood donors is critical for ensuring the safety of the donor blood supply, and donor deferral as a result of risk factors is...
12.
McManus H, Callander D, Asselin J, McMahon J, Hoy J, Templeton D, et al.
Am J Epidemiol
. 2021 Feb;
190(7):1386-1395.
PMID: 33534904
Ambitious World Health Organization targets for disease elimination require monitoring of epidemics using routine health data in settings of decreasing and low incidence. We evaluated 2 methods commonly applied to...
13.
Suraratdecha C, Stuart R, Edwards M, Moore R, Liu N, Wilson D, et al.
PLoS One
. 2020 Oct;
15(10):e0238499.
PMID: 33119591
Introduction: Great strides in responding to the HIV epidemic have led to improved access to and uptake of HIV services in Guyana, a lower-middle-income country with a generalized HIV epidemic....
14.
Pedrana A, Howell J, Scott N, Schroeder S, Kuschel C, Lazarus J, et al.
Lancet Gastroenterol Hepatol
. 2020 Jul;
5(10):927-939.
PMID: 32730786
WHO has set global targets for the elimination of hepatitis B and hepatitis C as a public health threat by 2030. However, investment in elimination programmes remains low. To help...
15.
Scott N, Kuschel C, Pedrana A, Schroeder S, Howell J, Thompson A, et al.
Lancet Gastroenterol Hepatol
. 2020 Jul;
5(10):940-947.
PMID: 32730785
Major gains in reducing the burden of hepatitis C are now possible because of the discovery of a cure. The prevention of premature deaths and increased workforce participation among people...
16.
Minnery M, Mathabela N, Shubber Z, Mabuza K, Gorgens M, Cheikh N, et al.
PLoS One
. 2020 Jul;
15(7):e0235664.
PMID: 32701968
Introduction: Eswatini achieved a 44% decrease in new HIV infections from 2014 to 2019 through substantial scale-up of testing and treatment. However, it still has one of the highest rates...
17.
Wilson D
Viruses
. 2020 Apr;
12(4).
PMID: 32326043
Since its introduction, the Triangulation number has been the most successful and ubiquitous scheme for classifying spherical viruses. However, despite its many successes, it fails to describe the relative angular...
18.
Stuart R, Wilson D
Int J Drug Policy
. 2020 Mar;
88:102702.
PMID: 32173275
Background: The global HIV response needs to both integrate with the broader health system and tackle the structural drivers of HIV. Cross-sectoral financing arrangements in which different sectors agree to...
19.
Scott N, Sacks-Davis R, Wade A, Stoove M, Pedrana A, Doyle J, et al.
Med J Aust
. 2020 Mar;
212(8):365-370.
PMID: 32167586
Objectives: To assess progress in Australia toward the 2030 WHO hepatitis C elimination targets two years after the introduction of highly effective direct-acting antiviral (DAA) treatments. Design: Analysis of quarterly...
20.
Stuart R, Kelly S, Martin-Hughes R, Wilson D
AIDS
. 2020 Jan;
34(3):439-446.
PMID: 31996595
Objective: Prices of antiretroviral (ARV) drugs in lower income countries have decreased substantially over the past two decades, helping to facilitate greatly expanded access to antiretroviral therapy (ART). However, ART...